Mepolizumab has had a bumpy road to arriving at its indication in COPD. An FDA advisory committee in 2018 declined to ...

The FDA will limit the vaccine’s availability later this year to older adults and those who may be at risk of severe illness.

The vaccine is expected to remain available for anyone who is at least 65 or who has a medical condition, leaving many Americans ineligible. Here's what we know.

The approval tees GSK up to challenge Sanofi and Regeneron, which in September 2024 won the first biologic approval for COPD ...

The FDA plans to limit access to certain high-risk groups and also told Pfizer and Moderna to update their warning labels ...

The FDA approved three natural food additives. Food and nutrition experts share what that means for families and our food ...

The Food and Drug Administration says it has decided to continue approving COVID-19 vaccine updates for seniors and others at ...

While research suggests having a higher weight may increase your risk for certain conditions, people can be healthy at every ...

Only one fourth of sunscreens on store shelves in the United States deliver safe and effective protection against the harmful rays of the sun, according to an annual report which analyzed more than 2, ...

The agency is planning a new review process that could result in ingredient bans or additional labeling requirements, ...

The MAHA movement loves the idea of getting rid of synthetic dyes in foods. But manufacturers face challenges that could drive prices higher.

The U.S. Food and Drug Administration is reviewing the regulation and labeling of the abortion pill mifepristone following ...